oxytocin is associated with augmented activities of phospholipase A2, phospholipase C and prostaglandin endoperoxide H synthase (PGS). In early pregnancy, maintenance of the corpus luteum is associated with an absence of pulsatile PGF," secretion; an increase in endometrial inhibitors of phospholipase A2 and PGS contribute to the antiluteolytic alterations of PGF," secretion. Linoleic acid is a competitive inhibitor of arachidonic acid metabolism by PGS, and microsomal concentrations of free linoleic acid are increased in the endometrium of pregnant cattle. The trophoblast produces large quantities of interferon tau (IFN-T). Inhibition of increases in endometrial oestracliol receptor mRNA and protein are associated with intrauterine administration of recombinant (r) ovine (o) IFN-T in sheep. Intrauterine injections of rbovine (b) IFN-T in cattle (days [14] [15] [16] [17] altered endometrial function so that secretion of PGF2," from cultured endometrial epithelial cells was reduced. Antiluteolytic effects were not expressed in 20% of cows receiving IFN-T or rbIFN-a11 indicating that an inadequate endometrial responsiveness may contribute to embryo mortality. IFN-T may activate a signal transduction system similar to that induced by other type I IFNs; activation of an intracellular tyrosine kinase ultimately leads to activation of an IFN-stimulated response element to induce gene transcription. Biological responses associated with pregnancy and IFN-T treatment are integrated into a multifactorial antiluteolytic model. Strategies to enhance embryo survival could include supplementation with rIFN-T and alterations in endometrial responsiveness to this cytokine through dietary manipulation of lipid metabolism.
Introduction
Maternal recognition of pregnancy can be considered as the interaction between the maternal unit and products of conception that signals to the mother the need to maintain pregnancy. This dialogue can occur at various critical stages during pregnancy, but one critical process in ruminants involves paracrine regulation by the conceptus of the underlying endometrium that leads to an attenuation of luteolytic PGF2" secretion. This antiluteolytic effect of the conceptus (Thatcher et al., 1986) is the primary cause of maintenance of the corpus luteum in sheep and cattle and is the focus of this review. An understanding of the antiluteolytic process depends on a clear comprehension of the mechanisms regulating endometrial PGF2" secretion during the luteal and luteolytic phases of the oestrous cycle. With this understanding, the potential pathways by which interferon-i (IFN-T) acts on the endometrium can be elucidated and potential strategies implemented to improve embryo survival.
Mechanisms Regulating Endometrial PGF,a Secretion
The limiting factors controlling PGF," secretion are the availability of arachidonic acid and the rate of PGF," formation by prostaglandin endoperoxide H synthase (PGS). After a per od of progesterone priming, low amplitude pulses of PGF2" occur in both cyclic and pregnant sheep (Silvia et al., 1984) and cattle (Parkinson and Lamming, 1990) . After these initial increases in PGF2" secretion, large terminal pulses of PGF," develop in the cyclic animal that cause the final stages of regression of the corpus luteum. Endometrial oxytocin receptors are induced in the latter stages of the oestrous cycle of sheep and cattle, and there is a positive feedback loop between uterine PGF2" and luteal oxytocin secretion (Flint et al., 1986 ). Accordingly, a major focus of investigation has been the oxytocin signal transduction system that leads to enhanced PGF," secretion. A major second messenger system receiving intensive investigation in both species (Flint et al., 1986; Silvia and Raw, 1993; Lafrance and Goff, 1990) has been the oxytocin-induced increase in phospholipase C (PLC) activity leading to the metabolism of phosphatidylinositol bisphosphate to inositol triphosphate (IP3) and diacylglycerol (DAG). These intracellular messengers can contribute to enhanced PGF," secretion by enhancing PLA, activity (for example increased intracellular Ca2±), providing an additional source of arachidonic acid via the metabolism of DAG by DAG lipases, or through the action of protein kinase C after activation by DAG (Lafrance and Goff, 1990) . However, a series of recent investigations (Silvia and Raw, 1993; Silvia et al., 1994; Lee and Silvia, 1994 ) have disassociated to some degree the responsiveness of the PLC signal transduction system from the oxytocin-induced stimulation of PGF," in ovine endometrium.
For example, endometrial tissue from cyclic sheep on days 12, 14 and 16 displayed a clear oxytocin-induced increase in PGF2" secretion, whereas PLC activity did not increase in response to oxytocin until day 14 (Silvia and Raw, 1993 ). An additional study compared the dose-dependent effect of oxytocin on PLC activity and PGF," secretion in endometrial tissue from ovariectomized ewes treated with steroids to mimic luteal and follicular changes in the oestrous cycle (Silvia et al., 1994) . The dose of oxytocin required to increase PLC activity was ten times that required to stimulate PG.F2" secretion. Collectively, these findings indicate that the stimulatory effects of oxytocin on secretion of PGF" are mediated through mechanisms other than phosphatidylinositol-specific PLC. Lee and Silvia (1994) used endometrial tissues from ovariectomized ewes receiving steroid replacement to permit oxytocin-induced increases in PGF," secretion and demonstrated that a stimulator of PLA2 (melittin) enhanced PGF," secretion comparable to that induced by oxytocin. Furthermore, aristolochic acid (an inhibitor of PLA2) blocked the increase in PGF2" secretion induced by oxytocin and melittin. Inhibition of PLA, activity did not block the oxytocin-induced increase in PLC activity or the ability of arachidonic acid to enhance PGF," secretion. Thus, oxytocin appears to act through an intracellular mechanism proximal to PLA, to stimulate PGF,,, secretion. The potential PLA2 intracellular pathway, in addition to the latter stage responses of PLC, appears to be regulating PGF2" secretion during the pre-and luteolytic periods. These pathways and the regulation of PGS activity are likely candidates for antiluteolytic regulation during early pregnancy.
Regulatory Effects of Pregnancy on PGF,a Secretion
It is well documented that the dynamics of PGF, secretion are altered in early pregnancy of sheep and cattle compared with comparable stages of the oestrous cycle (see reviews of Thatcher et al., 1986 and Geisert et al., 1994) . Alterations in PGF2" secretion have been documented experimentally by monitoring differences between cyclic and pregnant animals in transitory patterns of PGF," secretion and oestradiol or oxytocin-induced alterations in PGF," secretion. It is clear that the luteolytic patterns of PGF,,, secretion are attenuated in early pregnancy. Furthermore, there is a slight species difference in the pattern of PGF," secretion during pregnancy. In cows, luteolytic pulses are abolished without a major increase in basal secretion of PGF2", whereas, in sheep, numbers of luteolytic PGF," pulses are reduced but basal secretion of PGF," is actually enhanced in early pregnancy.
Several recent reports have documented differences in lipid metabolism and intracellular regulatory pathways of endometrial tissue from cyclic and pregnant animals. In a comparison of endometrial PLA, activity between early pregnant and cyclic ewes on days 12, 14 and 16, PLA2 activity was decreased on day 14 and day 16 of pregnancy (Tamby et al., 1993) . Furthermore, endometrial homogenates from ewes at day 16 of pregnancy exerted a greater inhibition of pancreatic PLA2 activity than did homogenates from cyclic ewes. In endometrial tissue of pregnant sheep (days 12, 14 and 16), oxytocin induction of PLC activity was absent (Silvia and Raw, 1993) . However, oxytocin and arachidonic acid could induce PGF,a secretion at these times. Thus, the stimulatory effects of oxytocin appear to be manifested in a manner other than that involving phosphatidylinositol-specific PLC. The stimulatory effect of arachidonic acid may signify that arachidonic acid availability is limiting in tissues of pregnancy. This would be consistent with a decrease in endometrial PLA, activity during early pregnancy in sheep (Tamby ef al., 1993) .
Addition of Ca2± to the medium enhanced basal PGF," secretion of endometrial tissue from both cyclic and pregnant cattle at day 17 after oestrus, in both groups (Thatcher ef al., 1992) . Further addition of exogenous PLA, markedly enhanced basal secretion of PGF," in explants from pregnant but not from cyclic cows. Also, addition of arachidonic acid caused a marked stimulation of PGF2" secretion in both groups; however, the response was considerably less in explants from pregnancy. Thus, availability of arachidonic acid may be limiting basal secretion of PGF," in early pregnancy of cows. Alternatively, an inhibitor of PGS may also be present in early pregnancy.
Thatcher ef al. (1985) postulated that the antiluteolytic effect of the conceptus may be mediated by the induction of an intracellular molecule in endometrial tissue that inhibited the enzymatic conversion of arachidonic acid to PGF,". Studies using assays that monitored the ability of microsomes to convert arachidonic acid to PGF," (determination by radioimmunoassay or conversion of radiolabelled arachidonic acid to PGF," as monitored by HPLC) showed that an endometrial prostaglandin synthesis inhibitor was present in bovine endometrium and that its activity was enhanced during pregnancy (Gross et al., 1988; Danet-Desnoyers et al., 1993) . The EPSI presumably acted on PGS since both PGF" and PGE, were inhibited. EPSI was originally thought to be a protein (Gross ef al., 1988 ), but it is now known that EPSI is a lipophilic molecule(s) that can co-elute with BSA during purification (Danet-Desnoyers et al., 1993; Thatcher et al., 1994) . Lipid extraction followed by thin layer chromatography has revealed that EPSI activity migrates in the free fatty acid class. Separation of free fatty acids by HPLC resulted in the active component being highly enriched in linoleic acid, a fatty acid shown previously to inhibit PGS activity (Elattar and Lin, 1989) . Thus, linoleic acid is probably one of the molecules responsible for EPSI activity. Furthermore, linoleic acid was found to act as a competitive inhibitor towards PGS when added to the bovine microsome assay (Thatcher et al., 1994) . Thus, it is feasible that the conceptus alters lipid metabolism in the endometrium leading to increased availability of linoleic acid, inhibition of PGS activity, and decreased synthesis of PGF,". G. Danet-Desnoyers and W. W. Thatcher (unpublished observations) measured PGS inhibitory activity and amounts of free linoleic and arachidonic fatty acids in endometrial microsomes of cyclic (n = 3) and pregnant (n = 4) cows at day 17 after oestrus. Units of PGS inhibitory activity were greater in microsomes prepared from pregnant than from cyclic cows (Fig. 1) . Lipids from microsomes were extracted with chloroform and methanol (1:2). The chloroform phase was subjected to thin layer chromatography (hexane, ethyl ether and acetic acid [80:20:1 by volume]) to isolate free fatty acids. After extraction of free fatty acids from the TLC plate with chloroform:methanol (95:5), the free fatty acids were methylated and fatty acid methyl esters separated and quantified by gas chromatography.
The total amounts of unesterified linoleic and arachidonic acids in microsomal fractions were expressed as ng mg .1 protein. Endometrial microsomes from pregnant cows had higher linoleic acid concentrations and lower arachidonic acid concentrations than did cyclic cows (Fig. 1) . Consequently, the ratio of linoleic to arachidonic acids was higher in microsomes of pregnant cows. On the basis of the concentration of linoleic acid found in the microsomes and the inhibitory activity of linoleic acid in the PGS inhibition assay, all of the difference in PGS inhibitory activity between microsomes of cyclic and pregnant cows can be accounted for by the differences in linoleic acid concentrations.
The reduced concentration of free arachidonic acid in the microsomal fraction also supports the possibility that arachidonic acid may also be limiting in early pregnancy. Perhaps this is due to decreased PLA, activity as observed in sheep (Tamby et al., 1993) . Gene expression of endometrial PGS (2.8 Kb mRNA transcript) does not appear to be regulated by the conceptus (Salamonsen et al., 1991) . However, data concerning PGS indicators indicate that PGS is altered by endogenous endometrial inhibitors of enzymatic activity involved in prostaglandin biosynthesis. was collected daily and assayed for progesterone to determine the lifespan of the corpus luteum.
Injections were continued until day 24 after oestrus or until return to oestrus. On day 17 after oestrus, all cows were injected i.v. with 100 units oxytocin, and plasma collected at 15 min intervals for 2 h before and 4 h after oxytocin injection. Plasma was analysed for 13,14-dihydro,15-keto--PGF2 (PGFM). Recombinant oIFN-T extended the lifespan of the corpus luteum (27.5 ± 1.2 versus 19.2 ± 1.2 days; P < 0.01; Fig. 2a ) and interoestrous interval (30.5 ± 0.9 versus 20.6 ± 0.8 days; P < 0.01). Recombinant bIFN-T also extended the lifespan of the corpus luteum (29.0 ± 2.2 versus 21.4 ± 2.4 days; P < 0.05; Fig. 2b ) and interoestrous interval (31.5 ± 2.2 versus 22.6 ± 2.5 days; P < 0.05). Treatment with roIFN-r (Fig. 3a) and rbIFN--c (Fig. 3b) attenuated the oxytocin-induced increase in plasma PGFM (Fig. 3) . These results indicate that both roIFN-T and rbIFN-T are effective antiluteolytic agents that can extend corpus luteum function and inhibit oxytocin-induced secretion of uterine PGF," in cattle. However, it is important to indicate that significant variability between animals in the lifespan of the corpus luteum (24-29 days for roIFN-T and 27-35 days in rbIFN-T) and responsiveness to oxytocin were detected in response to both IFN-T treatments (Fig. 4b, d ). This type of animal variability is evident in previous studies with roIFN-T in sheep (Martal et al., 1990) and native bIFN-T in cattle (Helmer et al., 1989) . It , 1994) . A 50% inhibition of basal and oxytocin-induced secretion of PGF2a and PGE, from epithelial cells was obtained with a dose of 1 ng mV 1. This is a concentration that is within the reported ranges for Kd value estimates for oIFNI-T receptors in sheep endometrial tissue. The inhibition of prostaglandin secretion appears to be cell specific since PGF,a and PGE, secretion by st:omal cells was not altered by either IFN-T or oxytocin.
We recently evaluated the effect of treatment with rbIFN-T in vivo on endometrial oxytocin receptor concentrations and PGF,a secretion from endometrial epithelial cells in vitro (Meyer et al., 1994) .
Beginning on day 14 of the oestrous cycle, cows received twice daily (07:00 h and 19:00 h) injections (via intrauterine catheters) of 200 ug rbIEN-T plus 1.3 mg BSA or 1.5 mg BSA divided equally between the two uterine horns (rbIFNI-T group, n = 5; BSA control group, n = 5). Injections were continued until 07:00 h on day 17 and cows were slaughtered at 10:00 h on day 17 to recover reproductive tracts.
Uterine horns were assigned randomly (ipsilateral versus contralateral to corpus luteum) for collection of endometrium for cell culture or oxyLocin receptor determination. Endometrial epithelial cells were isolated from both treatment groups for culture as described elsewhere (Danet-Desnoyers et a)., 1994).
Epithelial cells were treated at confluency with 0, 2 or 50 ng rbIEN-T m1-1. After 24 h of rbIEN-T treatment, cells received oxytocin (2 x 10 7 rnol 1 I) and medium was sampled 0, 30 and 90 min later for analysis of PGF20. Oxytocin receptors were measured in endometrial membranes using a receptor assay validated with endometrial tissue from cows in oestrus (Kd = 2.08 x 10 -9 mol 1-1• Bmax = 2.135 pmol mg protein). Oxytocin receptor binding (percentage specific binding per 100 ug protein) was low in both treatments but slightly attenuated in the rbIENT-T treatment group (0.30 < 0.60 ± 0.07%, P < 0.05).
Although this treatment difference was detected, binding was low compared with the 35% specific binding for endometrium collected at oestrus. Secretion of PGF2" was affected by an interaction between in vivo treatment with rbIEN-T and in vitro rbIFN-T treatment and oxytocin (Fig. 5) . Treatment with pregnancy (Tamby et al., 1993) , expression of the annexin family of proteins in response to oIFN-T warrants investigation. The annexins are proteins that are associated with an inhibition of PLA, activity and a decrease in PGF,a secretion because of their abilities to bind Ca2± (Ca2± is required for PLA, activity) and complex with phospholipids in a manner that alters phospholipid availability to PLA, as a substrate (Davidson and Dennis, 1989) .
Collectively, experimental observations involving IFN-T as well as inferences drawn from responses to IFN-a in other species and cellular systems have led to the conceptual model depicted in Fig. 6 . This model accounts for the intracellular responses to IFN-T that lead to a coordinated antiluteolytic effect that decreases PGF2a secretion. This model is suggested only to provide a framework for future investigations into the antiluteolytic mechanisms that characterize the interaction between conceptus and endometrium. It is proposed that PGS is inhibited by IFN-T-induced mobilization of free linoleic acid (Fig. 6 ). This appears to be implemented by an enhancement in phospholipase or lipase activities associated with the IFN-T receptor. Regulation of phospholipases (for example PLC and PLA,) is an integral part of hormonal signal transduction systems (for example oxytocin) and may be involved in and leukotrienes to epoxy derivatives. This alteration in arachidonic acid metabolism is due to linoleic acid acting as a competitive inhibitor with arachidonic acid for PGS. Epoxy derivatives and linoleic acid have synergistic effects on interferon-stimulated gene expression through activation of transcription factors by tyrosine kinase (Fig. 6) . Alterations in IFN-T-regulated gene expression lead to changes in certain intracellular gene products that potentially regulate prostaglandin secretion (increases in annexins, lipases ( ± ) and inhibitory effects (directly or indirectly) on expression of oestradiol and oxytocin receptors (Fig. 6) . In other cellular systems (for example mammary gland), linoleic and arachidonic acids are signal transducers that amplify receptor signal transduction systems for control of gene expression. Thus, an IFN-T-induced increase in linoleic acid could enhance the efficiency of IFN-T-induced gene expression regulated through other pathways and directly inhibit synthesis of PGF". Subsequent alterations in oxytocin ( -) and oestradiol ( -) receptors plus the production of PLA, inhibitors would result in a coordinated attenuation in the lytic secretion of PGF,.
Antiluteolytic Strategies to Improve Embryo Survival
Supplementation of inseminated animals with exogenous IFN-T, during the period before the time of antiluteolytic signalling, is a means to compensate for potentially deficient secretion of IFN-T by conceptuses that are behind in their development. Such a treatment would attenuate endome trial secretion of PGF," and rescue a small percentage of normal embryos that might be developing at a slower rate. To date, amounts of available recombinant ovine and bovine IFN-T have been insufficient to allow field testing of the potential fertility-enhancing effects of these proteins. An alternative approach has been to use recombinant bovine interferon-a,1 (rbIFN-a), a protein with approximately 50% amino acid sequence similarity to bIFN-T and oIFN-T. There is considerable evidence that rbIFN-a can exert effects on the reproductive system that are characteristic of IFN-T: extension of corpus luteum lifespan (Plante et al., 1989) , binding to endometrial receptors (Hansen et al., 1989; Stewart ef al., 1987) , alteration in endometrial protein secretion (Salamonsen et al., 1988) , suppression of oxyLocin-induced secretion of PGF," in vivo (Plante et al., 1991) , and induction of 2',5'-oligoadenylate synthetase activity in endometrium (Barros ei al., 1991) .
A series of fertility experiments in sheep with rbIFN-u. have been promising (see review: Thatcher et al., 1994) . Twice daily injections of rbIFN-a (2 mg) increased conception rates by 92 versus 76% (injection days 12 to 16); 80 versus 65% (injection days 11 to 18); 76 versus 69% (injection days 11 to 18). In contrast, administration of rbIFN-a to cattle decreased conception rates by about 10% regardless of whether a once daily injection (20 mg) was given between day 14 and day 17, a single large dose (40 mg) was given on day 13, or a sequence of increasing doses (0.01 to 10 mg) was given between day 11 and day 19 after insemination (Thatcher ei al., 1994) . The rbIFN-a induced reduction in fertility was attributed to induced side effects of hyperthermia and acute decreases in plasma progesterone probably caused by decreased LH secretion.
The recombinant forms of bIFN-T are likely to be effective at lower doses than is rbIFNa and this may reduce the potential for side effects. We have recently examined the effects of intramuscular injections of rbIFN-T (0, 1 and 5 mg) on body temperature and plasma concentrations of progesterone in cattle (Meyer et al., 1994) . The 5 mg dose of rbIFN-T had a similar effect to rbIFN-a in that a hyperthermic response of 40.3°C rectal temperature was observed 4 h after the injection. Paralleling the temporal increase and subsequent decline in rectal temperature to normal was a temporal decrease in plasma progesterone concentrations. However, the 1 mg dose caused only a slight rise in rectal temperature to 39.5°C at 8 h after injection, and there was no alteration in plasma progesterone. This response is encouraging, and the antiluteolytic effect of a 1 mg dose given once or twice a day needs to be examined. A sustained release delivery system may need to be developed to obtain effective delivery of sufficient rbIFN-T to the uterus to prevent luteolysis but not induce detrimental side effects that compromise survival of the embryo.
In many of the studies carried out to document either in vivo (Helmer et al., 1989; Plante et al., 1989; Martal et al., 1990 ; Meyer et al., in press) or in vitro (Danet-Desnoyers et al., 1994) effects of rbIFN-a,
